[April 04, 2014]

Research and Markets: European Endocrine Function Testing Market 2014: Hospitals, Commercial Labs, Physician Offices, Ambulatory Care Centers

Research and Markets (http://www.researchandmarkets.com/research/7z5zdd/european) has announced the addition of the "European Endocrine Function Testing Market 2014: Hospitals, Commercial Labs, Physician Offices, Ambulatory Care Centers" report to their offering.

European Endocrine Function Testing Market 2014: Hospitals, Commercial Labs, Physician Offices, Ambulatory Care Centers is a unique market and technology assessment designed to help current suppliers and potential market entrants idenify and evaluate emerging opportunities and developed effective strategic responses. The study explores future trends; provides test volume and sales forecasts; compares features of leading analyzers; and profiles key competitors.

The report provides test volume and sales forecasts by country and market segment for the following assays: Cortisol, Estradiol, FSH, HCG, Gastrin, LH, Progesterone, PTH/IO PTH, Prolactin, T3, T3 Uptake, Free T3, T4, Free T4, TBG, Testosterone, Thyroglobulin Ab, TPO Ab and TSH.

During the next five years, the endocrine function testing market will undergo significant transformation. These changes will be caused by convergence of new and more stringent regulations; advances in diagnostic technologies, system engineering, automation, and IT; and intensifying competition. Some segments will start resembling commodity markets, where product positioning and cost per test are more critical than underlying technology. This evolving marketplace will create exciting opportunities for a variety of new instruments, reagent systems, and auxiliary products, such as specimen preparation devices, controls, calibrators and others.

For more information visit http://www.researchandmarkets.com/research/7z5zdd/european

[ Back To TMCnet.com's Homepage ]